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Introduction
　Pharyngeal constriction elicited by irritation of oral posterior mucosa is called the gag reflex (mild 
gagging).  The reflex is considered as a defense reflex that prevents food bolus from entering the pharynx. 
More strong and long-lasting stimulation of oral posterior mucosa and/or pharynx elicits simultaneous 
contraction of diaphragm and abdominal muscle, i.e. severe gagging.  A rapid increase in the internal 
pressure of the stomach is produced by the simultaneous contraction of these muscles, and the pressure 
spreads to the upper esophagus.  Thus, the role of severe gagging is known to prevent food bolus from being 
lodged in the pharyngo- laryngeal region and the upper esophagus.
　Concern about clinical problems related to severe gagging has been growing in recent years.  Severe 
gagging creates many problems when feeding children and performing routine dental treatment [1-3]. 
According to data reported by the Ministry of Health, Labour and Welfare in Japan, more than 4000 people 
died due to food bolus impaction in 2006.  
　The main role of severe gagging is considered to be the expulsion of food bolus from the upper 
airway.  However, little is known about the neural mechanism of severe gagging.  Pressing against 
the oropharyngeal mucosa using a spatula is usually employed to induce mild gagging.  Pressing the 
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oropharyngeal mucosa strongly elicits severe gagging, which is characterized in humans by a burst 
discharge of the abdominal muscles and a wide opened mouth [4].  However, it is difficult to adequately 
equalize the intensity of the pressure and, furthermore, to elicit severe gagging repeatedly using this 
method.  Thus an alternative method for severe gagging induction is preferable.  We have recently reported 
severe gagging can be elicited repeatedly by using high intensity and/or high frequency stimulation of 
the superior laryngeal nerve (SLN), which innervates the pharyngo-laryngeal region, in decerebrate rats 
[5].  Furthermore, the induction probability of severe gagging can be controlled by stimulus parameters 
of the SLN [5].  Afferents of the SLN are known to relay to the nucleus of the solitary tract in the medulla 
oblongata.  It is reported that the command of motor pattern in severe gagging is produced by reticular 
neurons located dorsomedial to the retrofacial nucleus in the medulla oblongata [6, 7].  However, what 
types of neurotransmitters or neural receptors are working in severe gagging has not been identified.  
　Severe gagging is considered to be one of the emetic responses.  In the vomiting reflex, one of the emetic 
responses, tachykinin NK1 receptors [7-10] and N-methyl-D-aspartate (NMDA) type glutamate receptors 
[11, 12], play crucial roles in the neuronal circuit of the vomiting reflex.  In this study, WIN51708 and 
MK-801 were selected as the NK1 and NMDA receptor antagonists, respectively, since these antagonists are 
known to cross the blood brain barrier (BBB) which protects the brain from changes in the intravascular 
levels of ions, amino acids, peptides, and other substances. This study aimed to identify neurotransmitters 
involved in the neural circuit of severe gagging elicited by SLN stimulation in decerebrate rats in order to 
deepen our understanding of the neuronal mechanisms of severe gagging.
Materials and Methods
　The experimental procedures were carried out in accordance with the Guiding Principles for the Care 
and Use of Animals in the Field of Physiological Science (Physiological Society of Japan, 2003).  These 
procedures were approved by the Institutional Animal Care and Use Committee in Kawasaki University of 
Medical Welfare (No. 08-018).
Surgical procedure
　Experiments were performed on Male-Sprague Dawley rats (weighing from 350 to 500g) that were 
anesthetized with an intraperitoneal injection of a mixture of urethane (0.7g/kg) and α-chloralose (0.06g/
kg).  When necessary, supplementary doses of a mixture of urethane (0.12g/kg) and α-chloralose (0.01g/
kg) were given.  Rectal temperature was maintained at 37-38 ℃ with a heating pad.  A polyethylene 
cannula was inserted into the trachea to maintain the patency of the respiratory tract.  Rats were fixed 
in a stereotaxic frame in the prone position, the parietal bones were removed, the dura was incised, 
and precollicular decerebration was performed.  The decerebration procedure was performed in order to 
eliminate cerebral function by transecting the brain at the midbrain level.  No further anesthetics were 
given after the decerebration.  The rats were then taken out of the frame and rotated to the supine position. 
Blood pressure of the femoral artery was monitored.  Normal saline was continuously infused through 
the femoral vein at a rate of 1.5ml/h.  The left superior laryngeal nerve (SLN) was dissected free from 
surrounding tissues and placed on bipolar electrodes.
3Neurotransmitters involved in severe gagging
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Stimulation and recording
　Severe gagging was elicited using three sets of pulse train stimulation of the SLN at 100Hz (interval: 
1.7 sec, intensity: 200-400 μA, pulse number: 10-50 pulses, duration: 0.3 ms).  Electromyographic activities 
(EMGs) of abdominal, suprahyoid and intercostal muscles were recorded using each bipolar tungsten 
electrode.  Severe gagging was identified by the activity patterns of these muscles.  The EMG of suprahyoid 
muscle was used to distinguish severe gagging from the swallowing reflex.  Respiration cycles were 
monitored using the EMG of the intercostal muscles.  All data were converted to digital format using 
an analog-to-digital converter (PowerLab, AD Instruments, Japan), and stored in a computer (Optiplex 
GX520, DELL, Japan).  The digitized data were analyzed using a software program (Chart ver.  5.0, AD 
Instruments, Japan).
Drug administration
　Non-peptide NK1 receptor antagonist, WIN51708 (1-2 mg/kg, SIGMA, Japan) was dissolved in Dimethyl 
Sulfoxide.  Non-competitive NMDA receptor antagonist, MK-801 (1 mg/kg, SIGMA, Japan) was dissolved 
in normal saline.  Drug administration was performed through the femoral vein.
Statistical analysis
　Data was analyzed by chi-square test.  Post-hoc test was performed using the test of the difference 
between two proportions with Ryan’s procedure [13].  Significance level was taken as p< 0.05.
Fig. 1   Typical EMGs of suprahyoid, intercostal and abdominal muscles induced by pulse train simulation of 
the superior laryngeal nerve (SLN).  Single pulse train simulation elicited burst activity of suprahyoid 
muscle, corresponding to swallowing movement (indicated by “S”).  Three sets of pulse train stimulation 
produced burst activity of abdominal muscle, corresponding to severe gagging (indicated by “G”).
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Results
Severe gagging and the swallowing reflex elicited by SLN stimulation
　Pulse train stimulation of the SLN (100 Hz, 200-400 μA, 10-50 pulses) elicited the swallowing reflex, 
which was characterized by burst activity of the suprahyoid muscle and transient inhibition of intercostal 
muscle activity (indicated by “S”, Fig. 1A).  When three sets of pulse train stimulation were applied to 
the SLN at 1.7 sec intervals, severe gagging, which was characterized by burst activity of the abdominal 
muscle, was elicited (indicated by “G”, Fig. 1B).
Effects of NK1 and NMDA receptor antagonists on severe gagging
　As described in the introduction, NK1 and/or NMDA receptors have been reported to be essential to 
elicit emetic responses such as retching and vomiting.  Therefore in this study, the effects of NK1 receptor 
antagonist (WIN51708) and NMDA receptor antagonist (MK-801) on severe gagging were examined by 
intravenous administration of these drugs.  
　Before intravenous administration of both antagonists, severe gagging was elicited by three sets of pulse 
train stimulation of the SLN in all rats.  Distinct changes in blood pressure and respiratory cycle were not 
observed after administration of both antagonists.  The administration of WIN51708 gradually diminished 
the probability of the induction of severe gagging and severe gagging was not elicited at 14 min after the 
administration (Fig. 2).  Severe gagging was elicited by SLN stimulation 60 min after the administration of 
WIN51708 in all rats.  The probability of the induction of severe gagging significantly decreased at 10 and 
14 min after the administration of WIN51708 when compared with pre-administration results (chi-square
 test and post-hoc test, n=7, p<0.05; Fig. 2).  Similarly, the administration of MK-801 diminished the 
Fig. 2   Effects of NK1 and NMDA antagonists on induction probability of severe gagging elicited by SLN 
stimulation.  Values are presented by means ± S.E.  Pretreatment of WIN51708 (n=7) and MK-801 (n=9) 
significantly diminished induction probability of severe gagging.  Each significance level (p<0.05) is 
showed by * and §.
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probability of the induction of severe gagging and it reached a minimum value at the 10 min point after 
administration (Fig. 2).  However, the induction probability of severe gagging did not recover to the control 
level even 60 min after the administration.  The probability of the induction of severe gagging significantly 
decreased at 10, 14 and 18 min after the administration of MK-801 (chi-square test and post-hoc test, n=9, 
p<0.05; Fig. 2). 
Discussion
Effect of NK1 receptor antagonist on severe gagging
　In the present study, intravenous administration of NK1 receptor antagonist WIN51708 significantly 
suppressed severe gagging.  Distinct changes in blood pressure and respiratory cycle were not observed 
after administration of WIN51708 (1-2mg/kg).  Synaptic transmission in the neural circuit of severe 
gagging seemed to be inhibited by the drug without it influencing the respiratory and circulatory center 
in medullary reticular formation.  This drug is reported to cross the blood brain barrier [14], thus, since 
precollicular decerebration was performed in this study, the binding site of WIN51708 would have been 
within the brainstem.  Therefore we must ask the question, at which location did WIN51708 act to diminish 
severe gagging?  The superior laryngeal nerve (SLN), whose stimulation was used for the induction of 
severe gagging, projects the nucleus of the solitary tract (NST) in the medulla oblongata.  Therefore, NST 
seems to be one candidate for the biding sites of WIN51708.  In this study, the SLN was stimulated at a 
high frequency and a relatively high intensity, which was considered as noxious stimulation.  Thus, it is 
possible that SLN stimulation activated unmyelinated fibers contained in the SLN and that release of 
substance P (SP) from these fibers was facilitated.  The basis of this discussion is as follows; NK1 receptor 
has a high affinity for SP, a tachykinin peptide.  The neurotransmitter consists of 11 amino-acid residues 
and is localized in unmyelinated slow conducting C-fibers [15].  The SP is known to be a neurotransmitter 
involved in emetic responses [8, 9] and wind-up pain [16].  Severe gagging is usually elicited by noxious 
stimulation in the pharynx and larynx due to food impaction or irritation of mucosa in this area.  Taken 
together, the NK1 receptor antagonists, WIN51708 might interrupt neural transmission from C-fibers of 
the SLN to secondary neurons of the NST.  
　On the other hand, it is reported that the vomiting reflex, which is a typical emetic response, is elicited 
via the NK1 receptor in the medullary area adjacent to the semicompact part of the nucleus ambiguus [7, 
17].  Aprepitant is a NK1 receptor antagonist, which has Food and Drug Administration (FDA) approval, 
and is widely used as antiemetic medicine in clinical fields.  Severe gagging is considered to be one of 
the emetic responses.  Therefore, it is possible that WIN51708 acts at the medullary area adjacent to 
the semicompact part of the nucleus ambiguus, where it is known to be activated by NST neurons [7]. 
Thus, the precise locations of the effective sites of WIN51708 remain unknown and further study using 
microinjection of the receptor antagonists should be performed in the future to resolve this issue.
　In contrast to this study’s findings, Watson et al. [8] reported that the NK1 receptor antagonist did not 
affect “mild” gagging which is characterized by pharyngeal constriction elicited by tactile stimulation 
of the pharyngeal mucosa in conscious ferrets.  Discrepancies between Watson et al.’s results and the 
present study may well be differences between “mild” and “severe” gagging.  Induction of severe gagging 
necessitates high frequency stimulation of the SLN.  As described above, the noxious stimulation should 
release SP, however SP would not be a causal agent in “mild” gagging elicited by tactile stimulation of 
the pharyngeal mucosa.  In addition, conscious ferrets were used in their study, whereas decerebrate rats 
were used in our study.  Gagging is one of the medullary reflexes and is influenced by inputs of the higher 
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nervous system such as the cerebral cortex and limbic system.  It is reported that gagging is facilitated by 
psychological factors such as certain smells, sounds and emotions [1, 18].  This may also be a reason for the 
discrepancies between the two studies.  
Effect of NMDA receptor antagonist on severe gagging
　Pretreatment of the NMDA receptor antagonist, MK-801 significantly diminished the induction of severe 
gagging.  MK-801 (1mg/kg) was intravenously administered, however distinct changes in blood pressure 
and respiratory cycle were not observed.  This drug is known to penetrate the blood brain barrier [19], thus, 
since precollicular decerebration was performed, the binding site of MK-801 would have been within the 
brainstem.
　Glutamate is a major excitatory neurotransmitter in the brain and spinal cord.  NMDA receptor is an 
ionotropic class of glutamate receptor.  NMDA receptors do not participate in normal synaptic transmission 
because of their voltage-dependent block by extracellular magnesium [20].  A repetitive drive of noxious 
afferents such as C-fibers decreases the magnesium block and channel opening time is prolonged [20]. 
NMDA receptors have received particular attention because of their crucial roles in excitatory synaptic 
transmission and plasticity such as wind-up pain and memory consolidation [20].  The high frequency 
electrical stimulation of the SLN applied in this study is considered as noxious in the pharyngo-laryngeal 
region.  Therefore, it is possible that SLN stimulation strongly activated C-fibers, and as a result, the 
magnesium blockade in the secondary neurons in the NST was released.  The results obtained by our 
experiment indicated that NMDA receptors in NST neurons might participate in a neural circuit of 
severe gagging.  In fact, many studies have indicated that vomiting reflex is inhibited by intravenous or 
subcutaneous administration of NMDA receptor antagonists such as CGS19755 and dextromethorphan in 
ferrets and cats [10-12].  
　Our previous study showed that emetic stimulations, e.g., emetic drug administration or hypoxia, 
promoted the induction of severe gagging [4, 21].  Conditioned taste aversion (CTA) is a well-known emetic 
response observed in rats. CTA is defined as the result of the association of a taste with gastrointestinal 
malaise produced by the intake of a toxin and it is considered as an alternative strategy for the vomiting 
reflex in rats.  It is reported that CTA is also inhibited by the intraperitoneal administration of an NMDA 
receptor antagonist, ketamine [22].  Moreover, we have recently reported that autonomic responses (e.g., 
relaxation of gastric fundus and decrease of blood pressure) induced in rats by emetic drugs were inhibited 
by the intravenous administration of MK-801 [5].  These studies strongly support that NMDA receptors 
mediate emetic responses such as CTA and autonomic signs associated with emesis.  Thus, we concluded 
that NMDA receptors participate in the induction of severe gagging.
　On the other hand, Furukawa et al. [23] have reported that intraventricular administration of the non-
NMDA receptor antagonist (NBQX), (but not NMDA receptor antagonist MK-801), significantly depressed 
retching and salivary secretion elicited by abdominal vagal afferents stimulation in decerebrate dogs.  They 
concluded that non-NMDA receptors in NST participated in the neural circuit of these emetic responses, 
since fourth ventricular injection of the drug would directly act on NST neurons.  Thus, non-NMDA and 
NMDA receptors might be involved in emetic responses induced by vagal afferent and SLN stimulation, 
respectively.  This assumption should be further investigated.  
Interaction between NK1 and NMDA receptors
　In this study, it was suggested that NK1 and NMDA receptors are involved in the neural circuit of severe 
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gagging.  However, the action sites of NK1 and NMDA receptors remained uncertain, because antagonists 
of these receptors were administered intravenously.  Thus, it seems to be impossible to investigate the 
interaction between the NK1 and NMDA receptors.  The interaction between NK1 and NMDA receptors in 
association with severe gagging should be discussed in a future microinjection study.
Conclusion
　This study aimed to identify neuronal receptors involved in severe gagging elicited by SLN stimulation 
in decerebrate rats.  Intravenous administration of WIN51708 or MK-801 significantly diminished the 
probability of the induction of severe gagging.  It is concluded that both NK1 and NMDA receptors could be 
involved in neural circuit of severe gagging.
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